CG Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $310K | Sell |
4,897
-14,123
| -74% | -$894K | 0.12% | 115 |
|
|
2016
Q3 | $1.21M | Sell |
19,020
-14,082
| -43% | -$897K | 0.45% | 65 |
|
|
2016
Q2 | $2.46M | Buy |
33,102
+22,666
| +217% | +$1.69M | 0.99% | 37 |
|
|
2016
Q1 | $697K | Buy |
+10,436
| New | +$697K | 0.28% | 81 |
|
|
2014
Q3 | – | Sell |
-44,644
| Closed | -$1.74M | – | 134 |
|
|
2014
Q2 | $1.74M | Sell |
44,644
-11,012
| -20% | -$428K | 0.73% | 53 |
|
|
2014
Q1 | $2.34M | Buy |
55,656
+3,078
| +6% | +$129K | 1.05% | 35 |
|
|
2013
Q4 | $1.73M | Buy |
+52,578
| New | +$1.73M | 0.79% | 46 |
|